Related Experiment Videos

Recent trends in the percutaneous treatment of chronic total coronary occlusions

J Dawn Abbott1, Kevin E Kip, Helen A Vlachos

  • 1Division of Cardiology, Rhode Island Hospital, Brown University, Providence, Rhode Island, USA.

Insights

Percutaneous coronary intervention (PCI) for chronic total occlusions (CTOs) decreased in frequency from 1997-2004. Success rates for CTO PCI did not improve, highlighting a need for advanced techniques and devices.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Devices

Background:

  • Percutaneous coronary intervention (PCI) for chronic total occlusions (CTOs) is technically challenging with lower success rates compared to non-CTO lesions.
  • Trends in CTO treatment during the interventional era require evaluation to understand current practices and outcomes.

Purpose of the Study:

  • To analyze trends in the prevalence and success rates of PCI for CTOs between 1997 and 2004.
  • To identify patient and lesion characteristics associated with PCI outcomes in CTOs.

Main Methods:

  • Retrospective analysis of 4,173 patients undergoing PCI from the National Heart, Lung, and Blood Institute Dynamic Registry.
  • Comparison of CTO (n=371) versus non-CTO (n=4,802) lesions across four recruitment waves over a 7-year period.
  • Multivariable analysis to determine factors influencing PCI success and failure in CTOs.

Main Results:

  • CTO lesion attempts decreased by 41% from 9.6% to 5.7% between 1997-2004.
  • Contemporary CTO lesions were longer, less likely to contain thrombus, and more often treated with stents.
  • Successful CTO intervention rates nonsignificantly decreased from 79.7% to 71.4%; female gender and absence of thrombus were associated with higher success, while severe non-cardiac disease increased failure risk.

Conclusions:

  • Despite evolving interventional practices, PCI attempts for CTOs became less frequent, and success rates did not improve between 1997 and 2004.
  • The findings suggest a need for novel operator techniques and improved device technologies to enhance percutaneous treatment of CTOs.
  • Further research into advanced CTO PCI strategies is warranted to improve patient outcomes.

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...